What is the recommended pediatric dosing of metoprolol (immediate‑release) for an acute hemodynamically stable supraventricular tachycardia in a child without contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Pediatric Dosing of Metoprolol for Acute Hemodynamically Stable SVT

There is no established pediatric dosing for immediate-release metoprolol in acute SVT, and it should not be used as a first-line agent in children. The FDA drug label explicitly states "No pediatric studies have been performed. The safety and efficacy of metoprolol tartrate in pediatric patients have not been established" 1.

Recommended Treatment Algorithm for Pediatric SVT

First-Line Interventions (Hemodynamically Stable)

  • Vagal maneuvers should be attempted first (Valsalva, ice to face for infants, carotid massage in older children) 2
  • Adenosine IV is the primary pharmacologic agent: 6 mg rapid IV push followed by 20 mL saline flush; repeat with 12 mg if needed 2

Second-Line Options When Adenosine Fails

The 2025 AHA/AAP guidelines now support IV sotalol as the preferred second-line agent for refractory SVT when expert consultation is unavailable 3. Recent evidence shows 50-90% conversion rates with IV sotalol in pediatric refractory SVT 4.

Alternative second-line agents include:

  • Amiodarone 5 mg/kg IV/IO 2
  • Procainamide 15 mg/kg IV/IO 2
  • Expert consultation strongly recommended before using these agents in stable patients

Why Metoprolol Is Not Recommended in Pediatric SVT

Critical gaps in evidence:

  • No FDA-approved pediatric dosing exists 1
  • Adult dosing (5 mg IV over 1-2 minutes, repeated every 5 minutes to maximum 15 mg) 5 cannot be extrapolated to children
  • Only a single 1983 case report describes metoprolol use in pediatric SVT 6, providing insufficient evidence for routine use
  • The 2016 ACC/AHA/HRS adult SVT guidelines recommend IV beta-blockers for adults 7, but these recommendations explicitly exclude pediatric patients

Safety concerns specific to children:

  • Risk of hypotension and bradycardia 5
  • Potential for myocardial depression in infants 2
  • Contraindicated in pre-excited atrial fibrillation/flutter (may accelerate ventricular response) 5

If Beta-Blockade Is Specifically Needed

Propranolol has more pediatric data than metoprolol:

  • High-dose oral propranolol (3.6 ± 1.0 mg/kg/day divided doses) shows 67.3% success for infant SVT prophylaxis 8
  • Adult IV propranolol dosing: 0.5-1 mg over 1 minute, up to total 0.1 mg/kg 5
  • Still lacks formal pediatric IV dosing guidelines

Common Pitfalls to Avoid

  1. Do not use verapamil in infants - Class III contraindication due to risk of myocardial depression, hypotension, and cardiac arrest 2
  2. Do not use AV nodal blockers (including any beta-blocker) in pre-excited SVT - may cause life-threatening acceleration 5
  3. Do not delay electrical cardioversion in truly unstable patients while attempting multiple medications 2
  4. Ensure continuous monitoring if any IV antiarrhythmic is used - have resuscitation equipment immediately available

Electrical Cardioversion

For stable patients failing pharmacologic therapy: 0.5-1 J/kg synchronized cardioversion, increase to 2 J/kg if unsuccessful 2

Bottom line: Use adenosine first, consider IV sotalol or amiodarone second (with expert consultation), and reserve electrical cardioversion for refractory cases. Metoprolol lacks pediatric evidence and should not be used.

References

Related Questions

What is the recommended metoprolol dosing (oral immediate‑release and acute IV) for an adult with supraventricular tachycardia who has no contraindications such as severe asthma, second‑ or third‑degree atrioventricular block, resting heart rate below 60 bpm, systolic blood pressure below 90 mm Hg, or acute decompensated heart failure?
In a patient with a history of supraventricular tachycardia who is taking metoprolol and presents with a heart rate of 60 bpm, no chest pain or shortness of breath, should there be any concern in the emergency department regarding the electrocardiogram?
What is the appropriate dose of metoprolol for supraventricular tachycardia?
Can oral metoprolol (beta-blocker) be given to a patient with tachycardia?
Is it appropriate to give a 5 mg intravenous (IV) push of metoprolol to a 39‑year‑old male patient who is tachycardic and has elevated blood pressure?
In a 30-year-old woman at 16 weeks gestation who has autosomal dominant polycystic kidney disease (ADPKD) and a father with ADPKD, should amniocentesis for prenatal diagnosis of ADPKD be performed to guide the decision to continue or terminate the pregnancy?
What is the price of Imbruvica (ibrutinib) per tablet?
What is the recommended metoprolol dosing (oral immediate‑release and acute IV) for an adult with supraventricular tachycardia who has no contraindications such as severe asthma, second‑ or third‑degree atrioventricular block, resting heart rate below 60 bpm, systolic blood pressure below 90 mm Hg, or acute decompensated heart failure?
How should I manage a 47-year-old male with right knee stiffness who has been taking glucosamine sulfate 750 mg, methylsulfonylmethane 250 mg, and diacerein 50 mg daily for three months with reasonable relief, but now presents with new pain in the left knee?
What is the appropriate oral amiodarone dosing regimen for a hemodynamically stable child with supraventricular tachycardia?
What is the recommended management of dyspnea in a patient with community‑acquired pneumonia, including oxygen targets, bronchodilator use, analgesia, and escalation to high‑flow nasal cannula, non‑invasive ventilation, or intubation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.